ArticleDrug design, development and therapy2022

New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation.

Abdallah E Abdallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.